4:40 PM
 | 
Apr 08, 2019
 |  BC Extra  |  Company News

Management tracks: WuXi AppTec, Kymab, Acceleron

WuXi AppTec Co. Ltd. (Shanghai:603259; HKSE:2359) hired Frederick Hausheer as CMO. He was CEO of Alpha Omega Oncology Services (San Antonio, Texas) and an associate partner at Alacrita Consulting (Waltham, Mass.).

Antibody company Kymab Group Ltd. (Cambridge, U.K.) hired Simon Sturge to succeed David Chiswell as CEO, effective May 1. Sturge was EVP global strategy, business development and global operations at Merck KGaA (Xetra:MRK). Chiswell will remain a scientific adviser.

Acceleron Pharma Inc. (NASDAQ:XLRN) said CMO Robert Zeldin has departed. The rare disease company is searching for a successor.

mRNA therapeutics company Translate Bio Inc. (NASDAQ:TBIO) hired Richard...

Read the full 468 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >